Narasimha Rao (@polythenia) 's Twitter Profile
Narasimha Rao

@polythenia

Neonatologist | Digital Health | MedEdTech

ID: 1923271674495107073

calendar_today16-05-2025 06:59:07

0 Tweet

0 Followers

74 Following

MCA Scientific Events (@mca_se) 's Twitter Profile Photo

#NECawareness day discount will end tomorrow! Secure your participation at best rate to be part of the #SIGNEC2025! 50% OFF Online Attendance โ€“ Use code: NEC50 15% OFF In-Person Attendance โ€“ Use code: NEC15 Register here๐Ÿ‘‰: bit.ly/SIGNEC2025-REGโ€ฆ minesh.khashu (tweeting in individual capacity) SIGNEC signec.org

#NECawareness day discount will end tomorrow! Secure your participation at best rate to be part of the #SIGNEC2025!

50% OFF Online Attendance โ€“ Use code: NEC50
15% OFF In-Person Attendance โ€“ Use code: NEC15

Register here๐Ÿ‘‰: bit.ly/SIGNEC2025-REGโ€ฆ
<a href="/mkrettiwt/">minesh.khashu (tweeting in individual capacity)</a> <a href="/SIGNECconf/">SIGNEC   signec.org</a>
Evidence-Based Neo (@ebneo) 's Twitter Profile Photo

Dyanne Imo-Ivoke & Joanna Preece review Anup Katheria et al's 2y Outcomes of the MINVI trial on UCM in nonvigourous infants. READ:buff.ly/zuZR0ef @actapaediatrica: buff.ly/HdU8atE 99nicu:buff.ly/pFl64pu #neotwitter #EBNEOreviews JAMA Network Open

Dyanne Imo-Ivoke &amp; Joanna Preece review <a href="/NeoAnup/">Anup Katheria</a> et al's 2y Outcomes of the MINVI trial on UCM in nonvigourous infants.
READ:buff.ly/zuZR0ef
@actapaediatrica: buff.ly/HdU8atE
99nicu:buff.ly/pFl64pu
#neotwitter #EBNEOreviews
<a href="/JAMANetworkOpen/">JAMA Network Open</a>
Nathan Sundgren, PhD, MD (@natetexsun) 's Twitter Profile Photo

If I had an OxyGenie what would my 3 wishes be... 1. More time in target sat range 2. Less time in hyperoxia range 3. Less time in hyoxemia range ๐Ÿงž"Your wish is my command" doi.org/10.1111/apa.17โ€ฆ The Incubator Podcast Evidence-Based Neo Michael Narvey ๐Ÿ‡จ๐Ÿ‡ฆ NANN

Dr. K. S. Gautham (@dr_ksgautham) 's Twitter Profile Photo

Completely free! Do you want to learn about neonatal respiratory topics in an engaging interactive way virtually, and participate in discussions about respiratory conundrums? If so, register for NeoLung! #neotwitter

Razia Aliani (@raziaaliani) 's Twitter Profile Photo

Most researchers are gettng rejected for WRONG reasons 3 top editors revealed their internal review process.. Here's what I learned (Save & Repost) โคต๏ธ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐˜๐—ถ๐˜๐—น๐—ฒ ๐—บ๐—ฎ๐˜๐˜๐—ฒ๐—ฟ๐˜€ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฎ๐—ป ๐˜†๐—ผ๐˜‚ ๐˜๐—ต๐—ถ๐—ป๐—ธ โ†’ 1 line max. No questions. Make it a statement about

Most researchers are gettng rejected for WRONG reasons
3 top editors revealed their internal review process..
Here's what I learned (Save &amp; Repost) โคต๏ธ 

๐—ฌ๐—ผ๐˜‚๐—ฟ ๐˜๐—ถ๐˜๐—น๐—ฒ ๐—บ๐—ฎ๐˜๐˜๐—ฒ๐—ฟ๐˜€ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฎ๐—ป ๐˜†๐—ผ๐˜‚ ๐˜๐—ต๐—ถ๐—ป๐—ธ
โ†’ 1 line max. No questions. Make it a statement about
Dr. K. S. Gautham (@dr_ksgautham) 's Twitter Profile Photo

Comprehensive state-of-the-art review of hypoxic-ischemic encephalopathy, hypothermia therapy and adjunctive therapies. I'm interested in thoughts of colleagues from India and other countries about these authors' interpretation of the results of the HELIX trial and their

Comprehensive state-of-the-art review of hypoxic-ischemic encephalopathy, hypothermia therapy and adjunctive therapies. 
I'm interested in thoughts of colleagues from India and other countries about these authors' interpretation of the results of the HELIX trial and their